Since the start of our funding in May 2016:
>$70m
Amount of combined funding awarded to bioMT-supported research project leaders in Phase 1, each of whom have received NIH R01 or R35 funding, often in conjunction with NSF funding and/or venture capital support.
6
Number of bioMT-supported research project leaders who will have graduated by the end of Phase 1.
75+
Number of research labs at Dartmouth using Core facilities (Molecular Tools Core and Molecular Interactions and Imaging Core).
205+
Number of bioMT-supported publications.
3
Number of small businesses formed as a result of bioMT support of entrepreneurial opportunities.